(Q46613718)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081299%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

title

Impact of sex on the survival of patients with hepatocellular carcinoma: a Surveillance, Epidemiology, and End Results analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081299%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1 reference

hepatocellular carcinoma

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081299%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Veronica Wendy Setiawan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081299%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

6

Heinz-Josef Lenz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081299%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

author name string

Diana L Hanna

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081299%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Josh Usher

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081299%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Jordan LoCoco

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081299%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Pritesh Chaudhari

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081299%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Anthony El-Khoueiry

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081299%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

language of work or name

English

0 references

publication date

31 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081299%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081299%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

volume

120

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081299%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

issue

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081299%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

page(s)

3707-3716

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081299%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

21 January 2018

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Epidemiology of primary and secondary liver cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Association of estrogen receptor alpha polymorphisms with susceptibility to chronic hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Selective estrogen receptor modulators inhibit hepatitis C virus infection at multiple steps of the virus life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Differential effects of estrogen/androgen on the prevention of nonalcoholic fatty liver disease in the male rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

A cis-acting regulatory variation of the estrogen receptor α (ESR1) gene is associated with hepatitis B virus-related liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Estrogen suppresses metastasis in rat hepatocellular carcinoma through decreasing interleukin-6 and hepatocyte growth factor expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Oestrogen attenuates tumour progression in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Influence of sex on the survival of patients with esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Gender disparities in metastatic colorectal cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Oral contraceptives and primary liver cancer among young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Oral contraceptives and primary liver cancer: temporal trends in three countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Trends in mortality from primary liver cancer in England and Wales 1975-92: influence of oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Better survival in female patients with hepatocellular carcinoma: oral contraceptive pills related?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Oral contraception and the risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Parity, age at first birth, and risk of death from liver cancer: Evidence from a cohort in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Parity and hepatocellular carcinoma. A population-based study in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

The normal menopause transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Hormone replacement therapy and cancer risk: A systematic analysis from a network of case‐control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Female hormone utilisation and risk of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Estrogen derivatives: novel therapeutic agents for liver cirrhosis and portal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Loss of estrogen-related receptor α promotes hepatocarcinogenesis development via metabolic and inflammatory disturbances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Androgen receptors in hepatocellular carcinoma and surrounding liver: relationship with tumor size and recurrence rate after surgical resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Activation of androgen receptor induces ID1 and promotes hepatocellular carcinoma cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Characterization of a glycine N-methyltransferase gene knockout mouse model for hepatocellular carcinoma: Implications of the gender disparity in liver cancer susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Racial and geographic disparities in the utilization of surgical therapy for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Reproductive factors and the risk of hepatocellular carcinoma in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Androgen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

Androgen and estrogen receptors in hepatocellular carcinoma and the surrounding liver in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

7 January 2021

Liver cancer: neonatal estrogen enhances induction by a carcinogen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

7 January 2021

Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

7 January 2021

Hepatocellular carcinoma in long-term oral contraceptive use.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

7 January 2021

p53 mutations in hepatocellular carcinoma related to oral contraceptive use

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

7 January 2021

Oral contraceptive-associated liver cell adenoma and hepatocellular carcinoma. Cytomorphology and mechanism of malignant transformation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

7 January 2021

Parity and Primary Liver Cancer Among Young Women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

7 January 2021

Estrogen receptor 1 gene as a tumor suppressor gene in hepatocellular carcinoma detected by triple-combination array analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

7 January 2021

Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

7 January 2021

Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

7 January 2021

Androgen and oestrogen receptors in hepatocellular carcinoma and surrounding liver parenchyma: impact on intrahepatic recurrence after hepatic resection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

7 January 2021

Androgen receptor in hepatocellular carcinoma as a prognostic factor after hepatic resection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28912

7 January 2021

Identifiers

DOI

10.1002/CNCR.28912

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081299%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1 reference